As of May 27
| +0.03 / +0.52%|
The 3 analysts offering 12-month price forecasts for Corcept Therapeutics Inc have a median target of 9.00, with a high estimate of 12.00 and a low estimate of 4.00. The median estimate represents a +54.91% increase from the last price of 5.81.
The current consensus among 3 polled investment analysts is to Buy stock in Corcept Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.